| scholarly article | Q13442814 |
| P50 | author | Endel John Orav | Q12362078 |
| Carolyn Ho | Q48604633 | ||
| Steven Colan | Q57424879 | ||
| P2093 | author name string | Calum A MacRae | |
| Andrew J Powell | |||
| Anne Marie Valente | |||
| Neal K Lakdawala | |||
| Allison L Cirino | |||
| Sarah P Evans | |||
| P2860 | cites work | Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy | Q81023368 |
| 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q82432332 | ||
| CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy | Q83220140 | ||
| Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance | Q84201659 | ||
| Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy | Q84352868 | ||
| Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers | Q84376942 | ||
| Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 | ||
| The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms | Q28203734 | ||
| Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy | Q28268916 | ||
| The Genetic Basis for Cardiomyopathy | Q29300961 | ||
| Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association | Q34111674 | ||
| American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro | Q34275552 | ||
| Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations | Q34591899 | ||
| Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy | Q34629550 | ||
| Update 2011: clinical and genetic issues in familial dilated cardiomyopathy | Q34930971 | ||
| Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. | Q35549595 | ||
| Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. | Q35584472 | ||
| Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy | Q35974901 | ||
| A contemporary approach to hypertrophic cardiomyopathy. | Q36511747 | ||
| Genetic testing for dilated cardiomyopathy in clinical practice | Q36882310 | ||
| Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype | Q37078466 | ||
| T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy | Q37160724 | ||
| Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy | Q37766178 | ||
| The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy | Q37766179 | ||
| Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. | Q38522479 | ||
| Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families | Q41342233 | ||
| New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics. | Q41836826 | ||
| Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy | Q44454565 | ||
| Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy | Q44607020 | ||
| Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. | Q50892184 | ||
| Effects of metallic implants on magnetic resonance imaging evaluation of Fontan palliation. | Q51538681 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy | Q57841280 | ||
| New Doppler echocardiographic applications for the study of diastolic function | Q77398448 | ||
| P433 | issue | 3 | |
| P921 | main subject | echocardiography | Q216933 |
| hypertrophic cardiomyopathy | Q1364270 | ||
| cardiac magnetic resonance imaging | Q5038325 | ||
| P304 | page(s) | 230-237 | |
| P577 | publication date | 2013-05-20 | |
| P1433 | published in | Circulation: Cardiovascular Genetics | Q15816430 |
| P1476 | title | Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy | |
| P478 | volume | 6 |
| Q88141785 | 2D speckle-tracking TTE-based quantitative classification of left ventricular myocardium in patients with hypertrophic cardiomyopathy by the presence or the absence of fibrosis and/or hypertrophy |
| Q38193960 | Almanac 2014: cardiomyopathies. |
| Q91825576 | Association of smoking and physical inactivity with MRI derived changes in cardiac function and structure in cardiovascular healthy subjects |
| Q28075470 | Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy |
| Q58106412 | Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy |
| Q39004331 | Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease. |
| Q30430827 | Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients? |
| Q48352108 | Left Ventricular Septal Hypertrophy in Elderly Patients With Aortic Stenosis |
| Q90023421 | Left ventricular torsion rate and the relation to right ventricular function in pediatric pulmonary arterial hypertension |
| Q34543914 | Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy |
| Q88286500 | Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy |
| Q64069692 | Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA |
| Q33167938 | Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy |
| Q37596065 | The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy |
| Q38904542 | Update on Echocardiographic Assessment in Diabetes Mellitus |
Search more.